Kimberley Burrows

Kimberley Burrows

Auto-generated profile, based on publicly available information

Kimberley Burrows

MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MFManuel A Ferreira
Manuel A Ferreira
JVJudith M Vonk
Judith M Vonk
HBHansjörg Baurecht
Hansjörg Baurecht
IMIngo Marenholz
Ingo Marenholz
CTChao Tian
Chao Tian
ACAagc Collaborators
Aagc Collaborators
This large-scale genome-wide association analysis of subjects with asthma, hay fever or eczema provides insights into the shared genetic basis of these allergic diseases. The findings suggest that these diseases partly co-occur because they share many genetic risk variants that dysregulate the expression of immune-related genes. Asthma, hay fever (or allergic rhinitis) and eczema (or atopic dermatitis) often coexist in the same individuals1, partly because of a shared genetic origin2,3,4. To identify shared risk variants, we performed a genome-wide association study (GWAS; n = 360,838) of a broad allergic disease phenotype that considers the presence of any one of these three diseases. We identified 136 independent risk variants (P < 3 × 10−8), including 73 not previously reported, which implicate 132 nearby genes in allergic disease pathophysiology. Disease-specific effects were detected for only six variants, confirming that most represent shared risk factors. Tissue-specific heritability and biological process enrichment analyses suggest that shared risk variants influence lymphocyte-mediated immunity. Six target genes provide an opportunity for drug repositioning, while for 36 genes CpG methylation was found to influence transcription independently of genetic effects. Asthma, hay fever and eczema partly coexist because they share many genetic risk variants that dysregulate the expression of immune-related genes.

6 September 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JMJosine L. Min
Josine L. Min
GHGibran Hemani
Gibran Hemani
EHEilis Hannon
Eilis Hannon
KDKoen F. Dekkers
Koen F. Dekkers
JCJuan Castillo-Fernandez
Juan Castillo-Fernandez
CRCaroline L. Relton
Caroline L. Relton

1 June 2019 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
SRSarah E. Reese
Sarah E. Reese
CXCheng-Jian Xu
Cheng-Jian Xu
HDHerman T. Den Dekker
Herman T. Den Dekker
MLMi Kyeong Lee
Mi Kyeong Lee
SSSinjini Sikdar
Sinjini Sikdar
SLStephanie London
Stephanie London
Epigenetic mechanisms, including methylation, can contribute to childhood asthma. Identifying DNA methylation profiles in asthmatic patients can inform disease pathogenesis. We sought to identify differential DNA methylation in newborns and children related to childhood asthma. Within the Pregnancy And Childhood Epigenetics consortium, we performed epigenome-wide meta-analyses of school-age asthma in relation to CpG methylation (Illumina450K) in blood measured either in newborns, in prospective analyses, or cross-sectionally in school-aged children. We also identified differentially methylated regions. In newborns (8 cohorts, 668 cases), 9 CpGs (and 35 regions) were differentially methylated (epigenome-wide significance, false discovery rate < 0.05) in relation to asthma development. In a cross-sectional meta-analysis of asthma and methylation in children (9 cohorts, 631 cases), we identified 179 CpGs (false discovery rate < 0.05) and 36 differentially methylated regions. In replication studies of methylation in other tissues, most of the 179 CpGs discovered in blood replicated, despite smaller sample sizes, in studies of nasal respiratory epithelium or eosinophils. Pathway analyses highlighted enrichment for asthma-relevant immune processes and overlap in pathways enriched both in newborns and children. Gene expression correlated with methylation at most loci. Functional annotation supports a regulatory effect on gene expression at many asthma-associated CpGs. Several implicated genes are targets for approved or experimental drugs, including IL5RA and KCNH2. Novel loci differentially methylated in newborns represent potential biomarkers of risk of asthma by school age. Cross-sectional associations in children can reflect both risk for and effects of disease. Asthma-related differential methylation in blood in children was substantially replicated in eosinophils and respiratory epithelium.

1 August 2019 in Hypertension
Verified
Journal Article
Open access
NKNabila Kazmi
Nabila Kazmi
GSGemma C Sharp
Gemma C Sharp
SRSarah E. Reese
Sarah E. Reese
FVFlorianne O. Vehmeijer
Florianne O. Vehmeijer
JLJari Lahti
Jari Lahti
CRCaroline L. Relton
Caroline L. Relton
Hypertensive disorders of pregnancy (HDP) are associated with low birth weight, shorter gestational age, and increased risk of maternal and offspring cardiovascular diseases later in life. The mechanisms involved are poorly understood, but epigenetic regulation of gene expression may play a part. We performed meta-analyses in the Pregnancy and Childhood Epigenetics Consortium to test the association between either maternal HDP (10 cohorts; n=5242 [cases=476]) or preeclampsia (3 cohorts; n=2219 [cases=135]) and epigenome-wide DNA methylation in cord blood using the Illumina HumanMethylation450 BeadChip. In models adjusted for confounders, and with Bonferroni correction, HDP and preeclampsia were associated with DNA methylation at 43 and 26 CpG sites, respectively. HDP was associated with higher methylation at 27 (63%) of the 43 sites, and across all 43 sites, the mean absolute difference in methylation was between 0.6% and 2.6%. Epigenome-wide associations of HDP with offspring DNA methylation were modestly consistent with the equivalent epigenome-wide associations of preeclampsia with offspring DNA methylation (R 2 =0.26). In longitudinal analyses conducted in 1 study (n=108 HDP cases; 550 controls), there were similar changes in DNA methylation in offspring of those with and without HDP up to adolescence. Pathway analysis suggested that genes located at/near HDP-associated sites may be involved in developmental, embryogenesis, or neurological pathways. HDP is associated with offspring DNA methylation with potential relevance to development.

13 October 2017 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
RARyan Arathimos
Ryan Arathimos
MSMatthew Suderman
Matthew Suderman
GSGemma C Sharp
Gemma C Sharp
KBKimberley Burrows
Kimberley Burrows
RGRaquel Granell
Raquel Granell
CRCaroline L. Relton
Caroline L. Relton
Asthma heritability has only been partially explained by genetic variants and is known to be sensitive to environmental factors, implicating epigenetic modifications such as DNA methylation in its pathogenesis. Using data collected in the Avon Longitudinal Study of Parents and Children (ALSPAC), we assessed associations of asthma and wheeze with DNA methylation at 7.5 and 16.5 years, at over 450,000 CpG sites in DNA from the peripheral blood of approx. 1000 participants. We used Mendelian randomization (MR), a method of causal inference that uses genetic variants as instrumental variables, to infer the direction of association between DNA methylation and asthma. We identified 302 CpGs associated with current asthma status (FDR-adjusted P value < 0.05) and 445 with current wheeze status at 7.5 years, with substantial overlap between the two. Genes annotated to the 302 associated CpGs were enriched for pathways related to movement of cellular/subcellular components, locomotion, interleukin-4 production and eosinophil migration. All associations attenuated when adjusted for eosinophil and neutrophil cell count estimates. At 16.5 years, two sites were associated with current asthma after adjustment for cell counts. The CpGs mapped to the AP2A2 and IL5RA genes, with a − 2.32 [95% CI − 1.47, − 3.18] and − 2.49 [95% CI − 1.56, − 3.43] difference in percentage methylation in asthma cases respectively. Two-sample bi-directional MR indicated a causal effect of asthma on DNA methylation at several CpG sites at 7.5 years. However, associations did not persist after adjustment for multiple testing. There was no evidence of a causal effect of asthma on DNA methylation at either of the two CpG sites at 16.5 years. The majority of observed associations are driven by higher eosinophil cell counts in asthma cases, acting as an intermediate phenotype, with important implications for future studies of DNA methylation in atopic diseases.

14 February 2019 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
HDHerman T. Den Dekker
Herman T. Den Dekker
KBKimberley Burrows
Kimberley Burrows
JFJanine F. Felix
Janine F. Felix
LSLucas A Salas
Lucas A Salas
INIvana Nedeljkovic
Ivana Nedeljkovic
LDLiesbeth Duijts
Liesbeth Duijts
Rationale: We aimed to identify differentially methylated regions (DMRs) in cord blood DNA associated with childhood lung function, asthma and chronic obstructive pulmonary disease (COPD) across the life course.Methods: We meta-analysed epigenome-wide data of 1688 children from five cohorts to identify cord blood DMRs and their annotated genes, in relation to forced expiratory volume in 1 s (FEV1), FEV1/forced vital capacity (FVC) ratio and forced expiratory flow at 75% of FVC at ages 7–13 years. Identified DMRs were explored for associations with childhood asthma, adult lung function and COPD, gene expression and involvement in biological processes.Results: We identified 59 DMRs associated with childhood lung function, of which 18 were associated with childhood asthma and nine with COPD in adulthood. Genes annotated to the top 10 identified DMRs wereHOXA5,PAOX,LINC00602,ABCA7,PER3,CLCA1,VENTX,NUDT12,PTPRN2andTCL1A. Differential gene expression in blood was observed for 32 DMRs in childhood and 18 in adulthood. Genes related with 16 identified DMRs were associated with respiratory developmental or pathogenic pathways.Interpretation: Our findings suggest that the epigenetic status of the newborn affects respiratory health and disease across the life course.